Evozyne
Updates & Highlights
Business Wire · over 2 years ago
Biotech Veteran Marc Yoskowitz Named Evozyne CEO
Pulse 2.0 · almost 3 years ago
Evozyne: Novel Protein Systems Company Closes $81 Million In Series B Funding
Crain's Chicago Business · almost 3 years ago
Evozyne raises $81 million to put AI to work on therapeutic drug development
Recent Openings
View all 2 jobs arrow_forwardAll Jobs
Culture & Mission
Benefits & Perks
Learning Budget
Professional development
Competitive Salary
Market-rate compensation
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Generous PTO
Paid time off
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Evozyne?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
15 recentBiotech Veteran Marc Yoskowitz Named Evozyne CEO
Biotech Veteran Marc Yoskowitz Named Evozyne CEO
Business Wire · over 2 years ago
Evozyne: Novel Protein Systems Company Closes $81 Million In Series B Funding
Evozyne: Novel Protein Systems Company Closes $81 Million In Series B Funding
Pulse 2.0 · almost 3 years ago
Evozyne raises $81 million to put AI to work on therapeutic drug development
Evozyne raises $81 million to put AI to work on therapeutic drug development
Crain's Chicago Business · almost 3 years ago
Generative AI-focused biotech startup Evozyne raises $81m
Generative AI-focused biotech startup Evozyne raises $81m
pharmaceutical-technology.com · almost 3 years ago
Evozyne Raises $81M in Series B Financing
Evozyne Raises $81M in Series B Financing
FinSMEs · almost 3 years ago
Biotech Biz Evozyne Closes $81M Series B Funding Round
Biotech Biz Evozyne Closes $81M Series B Funding Round
Law360 · almost 3 years ago
Evozyne Announces $81 Million Financing Round to Advance Generative AI for Therapeutic Discovery and Drug Development
Evozyne Announces $81 Million Financing Round to Advance Generative AI for Therapeutic Discovery and Drug Development
Business Wire · almost 3 years ago
Startup Evozyne identifies ‘supernatural’ proteins with Nvidia’s pretrained AI model
Startup Evozyne identifies ‘supernatural’ proteins with Nvidia’s pretrained AI model
drugdiscoverytrends.com · over 3 years ago
Evozyne Uses NVIDIA BioNeMo to Create Proteins and Accelerate Drug Discovery
Evozyne Uses NVIDIA BioNeMo to Create Proteins and Accelerate Drug Discovery
StorageReview.com · over 3 years ago
NVIDIA, Evozyne Create Generative AI Model for Proteins
NVIDIA, Evozyne Create Generative AI Model for Proteins
NVIDIA Blog · over 3 years ago
Mike Gamson takes over as CEO at biotech startup Evozyne
Mike Gamson takes over as CEO at biotech startup Evozyne
The Business Journals · over 3 years ago
Tech exec Mike Gamson named CEO at biotech startup Evozyne
Tech exec Mike Gamson named CEO at biotech startup Evozyne
Crain's Chicago Business · over 3 years ago
Evozyne, Takeda ink $400M deal
Evozyne, Takeda ink $400M deal
Crain's Chicago Business · over 4 years ago
Takeda/Evozyne Partnership Headlines Hot Week for Gene Therapy Deals
Takeda/Evozyne Partnership Headlines Hot Week for Gene Therapy Deals
BioSpace · over 4 years ago
Takeda's gene therapy hunger not yet quelled as Evozyne pact extended for $400M in biobucks
Takeda's gene therapy hunger not yet quelled as Evozyne pact extended for $400M in biobucks
Fierce Biotech · over 4 years ago